| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02552121) | Seagen Inc. | 2015-11-30 |
| Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer (NCT02500121) | Matthew Galsky | 2015-11-11 |
| Diode Laser Treatment of Bladder Tumors (NCT02738827) | Gregers Gautier Hermann | 2015-11-01 |
| Study of Tumour Focused Radiotherapy for Bladder Cancer (NCT02447549) | Institute of Cancer Research, United Kingdom | 2015-10-21 |
| A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) (NCT02563561) | Spectrum Pharmaceuticals, Inc | 2015-10-09 |
| A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting (NCT02560584) | Photocure | 2015-10-01 |
| Metformin and Simvastatin Use in Bladder Cancer (NCT02360618) | London Health Sciences Centre | 2015-10-01 |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer (NCT02543645) | Celldex Therapeutics | 2015-10-01 |
| Decipher Genomics Resource for Intelligent Discovery (NCT02609269) | GenomeDx Biosciences Corp | 2015-10-01 |
| Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) (NCT02553642) | Memorial Sloan Kettering Cancer Center | 2015-09-14 |
| VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer (NCT02371447) | Swiss Cancer Institute | 2015-09-08 |
| Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer (NCT02861196) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2015-09-01 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT) (NCT02555163) | Mansoura University | 2015-09-01 |
| Comparing Rectus Sheath Catheter to Epidural Post Cystectomy (NCT02572804) | Vancouver Coastal Health | 2015-09-01 |
| Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG (NCT02449239) | Sesen Bio, Inc. | 2015-08-01 |
| Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy (NCT02655081) | University of Pittsburgh | 2015-07-01 |
| Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure (NCT02365818) | CG Oncology, Inc. | 2015-06-02 |
| MK-3475/BCG in High Risk Superficial Bladder Cancer (NCT02324582) | Southern Illinois University | 2015-06-01 |
| Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects (NCT02365766) | Jason R. Brown | 2015-05-27 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| Measuring Surgical Recovery After Radical Cystectomy (NCT03193970) | M.D. Anderson Cancer Center | 2015-04-30 |
| High Resolution Imaging for Early and Better Detection of Bladder Cancer (NCT02340650) | The University of Texas Health Science Center, Houston | 2015-04-01 |
| Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors (NCT02197897) | Baylor College of Medicine | 2015-04-01 |
| Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study (NCT04194112) | Mansoura University | 2015-04-01 |
| Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes (NCT02373735) | Asan Medical Center | 2015-03-01 |
| Determinants of Bladder Cancer Recurrence Study (The DETER Study) (NCT02400944) | Memorial Sloan Kettering Cancer Center | 2015-03-01 |
| Role of Low-intensity Shock Wave Therapy in Penile Rehabilitation Post Nerve Sparing Radical Cysto-prostatectomy (NCT02422277) | Mansoura University | 2015-03-01 |
| Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer (NCT02300610) | H. Lee Moffitt Cancer Center and Research Institute | 2015-02-11 |
| Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) (NCT02346955) | Famewave Ltd. | 2015-02-01 |
| Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression (NCT02443844) | Diskapi Teaching and Research Hospital | 2015-02-01 |
| A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] (NCT02302807) | Hoffmann-La Roche | 2015-01-13 |
| Bakircay University Cigli Training and Research Hospital (NCT04683536) | Recep Tayyip Erdogan University Training and Research Hospital | 2015-01-01 |
| Circulating Tumor DNA Exposure in Peripheral Blood (NCT03517332) | Quantgene Inc. | 2015-01-01 |
| Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder Cancer (NCT04110483) | I.M. Sechenov First Moscow State Medical University | 2015-01-01 |
| Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients (NCT02307487) | UroGen Pharma Ltd. | 2014-12-01 |
| Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block (NCT02452944) | Gachon University Gil Medical Center | 2014-12-01 |
| Enhanced Recovery After Radical Cystectomy Study (NCT02328417) | Carlos Llorente | 2014-12-01 |
| Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (NCT02188446) | Rigshospitalet, Denmark | 2014-11-01 |
| Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer (NCT02281383) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer (NCT02070120) | Institute of Cancer Research, United Kingdom | 2014-10-01 |
| Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors (NCT02233842) | National Cancer Institute (NCI) | 2014-09-01 |
| Alisertib in Chemotherapy-pretreated Urothelial Cancer (NCT02109328) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2014-08-28 |
| IFACT: Incidental Findings in Advanced Cancer Therapy (NCT02217891) | Memorial Sloan Kettering Cancer Center | 2014-08-01 |
| Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients (NCT02785887) | Azienda USL 4 Prato | 2014-08-01 |
| Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders (NCT02174185) | Huazhong University of Science and Technology | 2014-08-01 |
| A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. (NCT02186925) | Meir Medical Center | 2014-08-01 |
| Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers (NCT02178722) | Incyte Corporation | 2014-07-17 |
| T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive (NCT02153905) | National Cancer Institute (NCI) | 2014-07-03 |
| MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer (NCT02662166) | Turku University Hospital | 2014-07-01 |
| Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin (NCT02030574) | Brown University | 2014-07-01 |
| Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging (NCT02203136) | M.D. Anderson Cancer Center | 2014-06-25 |
| LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer (NCT02164942) | Wake Forest University Health Sciences | 2014-06-01 |
| A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) (NCT02108652) | Hoffmann-La Roche | 2014-05-31 |
| A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) (NCT02951767) | Hoffmann-La Roche | 2014-05-31 |
| A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy (NCT02145871) | Memorial Sloan Kettering Cancer Center | 2014-05-21 |
| Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers (NCT02141490) | National Cancer Institute (NCI) | 2014-05-15 |
| Hyperthermic Intra-Vesical Chemotherapy (NCT06768346) | Queen Mary University of London | 2014-05-08 |
| FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors (NCT02149862) | Rennes University Hospital | 2014-05-01 |
| Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization (NCT02287701) | NYU Langone Health | 2014-05-01 |
| My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors (NCT02091141) | Genentech, Inc. | 2014-04-14 |
| Blue Light Cystoscopy With Cysview® Registry (NCT02660645) | Photocure | 2014-04-01 |
| A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function (NCT02665039) | Dr Anders Ullén | 2014-04-01 |
| Study of Weekly Radiotherapy for Bladder Cancer (NCT01810757) | Institute of Cancer Research, United Kingdom | 2014-04-01 |
| Trimodality Treatment in Bladder Cancer (NCT06395701) | Consorci Sanitari de Terrassa | 2014-04-01 |
| Prospective Analysis of Robot-Assisted Surgery (NCT02292914) | Instituto do Cancer do Estado de São Paulo | 2014-03-10 |
| Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer (NCT02143804) | CG Oncology, Inc. | 2014-03-01 |
| Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy (NCT02050451) | Vanderbilt University | 2014-03-01 |
| Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (NCT01438112) | CG Oncology, Inc. | 2014-03-01 |
| Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer (NCT02074189) | Southwest Hospital, China | 2014-03-01 |
| Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) (NCT02080650) | Duke University | 2014-03-01 |
| Molecular Markers of Chemosensitivity for Bladder Cancer (NCT02074241) | Southwest Hospital, China | 2014-03-01 |
| New Technique for Uretero-ileal Anastomosis for Patient With Bladder Cancer Who Are Suitable for Orthotopic Neobladder (NCT04162093) | Ain Shams University | 2014-02-01 |
| Biomarker Identification for Bladder Cancer Patients (NCT02053662) | Ohio State University Comprehensive Cancer Center | 2014-01-21 |
| Detection of K14 in Bladder Cancer With a Non Invasive Technique (NCT02027649) | Corporacion Parc Tauli | 2014-01-01 |
| Open Versus Laparoscopic Radical Cystectomy (NCT02345499) | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 2014-01-01 |
| Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG (NCT02015104) | National Cancer Institute (NCI) | 2013-12-18 |
| CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) (NCT02043665) | Viralytics | 2013-12-18 |
| A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies (NCT01060319) | Stanford University | 2013-12-01 |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT (NCT02010203) | Heat Biologics | 2013-12-01 |
| Information Improvement for Surgical Patients Through Portable Video Media (NCT02846467) | Hospital Universitario Puerto Real | 2013-12-01 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623) | Seagen Inc. | 2013-11-30 |
| Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. (NCT06167356) | IRCCS San Raffaele | 2013-11-27 |
| Intravesical BCG Administration to Patients With Invasive Bladder Cancer (NCT02365207) | The University of Texas Health Science Center at San Antonio | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer (NCT02326168) | The University of Texas Health Science Center at San Antonio | 2013-10-01 |
| Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment (NCT01955408) | Meir Medical Center | 2013-09-30 |
| An Educational Intervention for Patients With Bladder Cancer (NCT01915121) | Icahn School of Medicine at Mount Sinai | 2013-09-01 |
| Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer (NCT02092948) | Jonsson Comprehensive Cancer Center | 2013-08-22 |
| Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development (NCT02106416) | NYU Langone Health | 2013-08-01 |
| Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer (NCT01916109) | Memorial Sloan Kettering Cancer Center | 2013-08-01 |
| PET/MRI and Biomarkers in Bladder Cancer (NCT01918592) | Turku University Hospital | 2013-08-01 |
| Adjuvant Radiation for High Risk Bladder Cancer (NCT01954173) | Emory University | 2013-07-22 |
| Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE" (NCT01935466) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-07-01 |
| Single Subject Neratinib in Bladder Cancer (NRR) (NCT01956253) | UNC Lineberger Comprehensive Cancer Center | 2013-07-01 |
| Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer (NCT02948543) | University of Sydney | 2013-07-01 |
| Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study (NCT01868087) | Jill Hamilton-Reeves, PhD RD LD | 2013-07-01 |
| Tranexamic Acid During Cystectomy Trial (TACT) (NCT01869413) | Ottawa Hospital Research Institute | 2013-06-01 |
| Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy (NCT01836978) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2013-06-01 |
| BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS (NCT02505516) | UFUOMA MILLER FAKPOR | 2013-06-01 |